Potential effects of bisphosphonates on bone ultrastructure

[1]  S. Boonen,et al.  Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  N. Watts,et al.  Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy , 2008, Osteoporosis International.

[3]  Paul Roschger,et al.  Evidence that Treatment with Risedronate in Women with Postmenopausal Osteoporosis Affects Bone Mineralization and Bone Volume , 2007, Calcified Tissue International.

[4]  P. Fratzl,et al.  Bone Material Properties in Trabecular Bone From Human Iliac Crest Biopsies After 3‐ and 5‐Year Treatment With Risedronate , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  S M Jorgensen,et al.  Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography. , 2006, Bone.

[6]  P. Fratzl,et al.  Effects of 3‐ and 5‐Year Treatment With Risedronate on Bone Mineralization Density Distribution in Triple Biopsies of the Iliac Crest in Postmenopausal Women , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  E. Ritman,et al.  The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover. , 2005, Bone.

[8]  R. Recker,et al.  Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study , 2004, Osteoporosis International.

[9]  P. Fratzl,et al.  Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. , 2001, Bone.

[10]  P. Meunier,et al.  Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. , 2000, Bone.

[11]  Lynn Wei,et al.  Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. , 1997, The Journal of clinical investigation.